DarioHealth Corp (DRIO) Stock Analysis

DarioHealth Corp (DRIO) is a publicly traded company in the HEALTHCARE sector. It trades at $7.40, carries a market capitalization of $56.30M. This page summarizes the public market data, fundamentals, and frequently asked questions for DRIO, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - HEALTH INFORMATION SERVICES

Exchange: NASDAQ

Key Metrics

Market Sentiment

DarioHealth Corp currently has a Bullish sentiment score of 0.52.

About DarioHealth Corp

DarioHealth Corp. is a pioneering digital health company headquartered in New York, NY, dedicated to transforming the management of chronic conditions through personalized digital therapies, with a strong focus on diabetes, hypertension, and weight management. By leveraging cutting-edge technology and robust data analytics, DarioHealth provides innovative mobile health solutions that promote real-time patient monitoring and customized interventions. This comprehensive platform significantly e...

GNG Research Analysis

GNG Research scores DarioHealth Corp (DRIO) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for DRIO.

Frequently Asked Questions

Does DRIO pay dividends?

DarioHealth Corp (DRIO) does not currently pay a regular dividend.

What is DRIO's market cap?

DarioHealth Corp (DRIO) has a market capitalization of $56.30M with a current stock price of $7.40.